Pancreatic Cancer Research

ResearcherInstitute of Cancer ResearchActive in the last 2 years

Petros Mouratidis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7248-6076; OpenAlex author ID A5008668000. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation. Co-author DOI 10.14366/usg.25199↗
  2. Latest Advances in the Use of Therapeutic Focused Ultrasound in the Treatment of Pancreatic Cancer. Co-author DOI 10.3390/cancers14030638↗
  3. Pulsed focused ultrasound can improve the anti-cancer effects of immune checkpoint inhibitors in murine pancreatic cancer. Co-author DOI 10.1098/rsif.2021.0266↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gail ter Haar · 2 shared papers, 2021–2022 · strength 0.50
  2. Chrit T. W. Moonen · 1 shared paper, 2026 · strength 0.29
  3. Timothy N. J. Bullock · 1 shared paper, 2026 · strength 0.29
  4. Jae Young Lee · 1 shared paper, 2026 · strength 0.29
  5. Joan Vidal-Jové · 1 shared paper, 2026 · strength 0.29
  6. Holger Grüll · 1 shared paper, 2026 · strength 0.29
  7. Cyril Lafon · 1 shared paper, 2026 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.